Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.
作者信息
Cremieux A C, Carbon C
机构信息
Service de Médecine Interne, Institut National de la Santé et de la Recherche Médicale U13, Hopital Bichat-Claude Bernard, Paris, France.
出版信息
Antimicrob Agents Chemother. 1992 Oct;36(10):2069-74. doi: 10.1128/AAC.36.10.2069.
Abstract
摘要
相似文献
1
Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.
Antimicrob Agents Chemother. 1992 Oct;36(10):2069-74. doi: 10.1128/AAC.36.10.2069.
2
Pharmacokinetic and pharmacodynamic aspects of therapy of experimental endocarditis.
Infect Dis Clin North Am. 1993 Mar;7(1):37-51.
3
"Difficult to treat infections" pharmacokinetic and pharmacodynamic factors--a review.
Acta Microbiol Immunol Hung. 2000;47(1):1-8.
4
[Antibiotic treatment of endocarditis : Partial Oral Treatment of Endocarditis Trial (POET)].
Internist (Berl). 2019 Jul;60(7):769-772. doi: 10.1007/s00108-019-0600-0.
5
The long journey of outpatient parenteral antibiotic therapy in infective endocarditis: from idea to clinical guidelines.
South Med J. 2009 Jun;102(6):559-60. doi: 10.1097/SMJ.0b013e3181a59750.
6
Cochrane corner: a comparison of antibiotic regimens for the treatment of infective endocarditis.
Heart. 2021 Mar;107(5):355-357. doi: 10.1136/heartjnl-2020-317891. Epub 2020 Dec 23.
7
[Contribution of the experimental model of bacterial endocarditis].
Bull Acad Natl Med. 1995 Apr;179(4):767-74; discussion 775-6.
8
Assessment of the feasibility of a partial oral regimen for antibiotic therapy of endocarditis.
Intern Emerg Med. 2019 Apr;14(3):475-477. doi: 10.1007/s11739-019-02067-7. Epub 2019 Mar 12.
9
[Antibiotic treatment of severe bacterial diseases in internal medicine (sepsis, meningitis, endocarditis)].
Dtsch Med J. 1972 Apr 9;23(4):275-80.
10
Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy.
J Antimicrob Chemother. 2004 Dec;54(6):971-81. doi: 10.1093/jac/dkh474. Epub 2004 Nov 16.
引用本文的文献
1
Antimicrobial Use Among Outpatients at Benjamin Mkapa Hospital in Dodoma Central Zone of Tanzania: A Prospective Descriptive Study.
Infect Dis Clin Microbiol. 2024 Sep 26;6(3):174-184. doi: 10.36519/idcm.2024.394. eCollection 2024 Sep.
2
Anti-biofilm Approach in Infective Endocarditis Exposes New Treatment Strategies for Improved Outcome.
Front Cell Dev Biol. 2021 Jun 18;9:643335. doi: 10.3389/fcell.2021.643335. eCollection 2021.
3
Investigation of antimicrobial use at a tertiary care hospital in Southern Punjab, Pakistan using WHO methodology.
Antimicrob Resist Infect Control. 2017 Apr 28;6:41. doi: 10.1186/s13756-017-0199-7. eCollection 2017.
4
WHO/INRUD prescribing indicators and prescribing trends of antibiotics in the Accident and Emergency Department of Bahawal Victoria Hospital, Pakistan.
Springerplus. 2016 Nov 8;5(1):1928. doi: 10.1186/s40064-016-3615-1. eCollection 2016.
5
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.
Clin Ther. 2016 Sep;38(9):1930-47. doi: 10.1016/j.clinthera.2016.06.015. Epub 2016 Jul 20.
6
Comparison of six generic vancomycin products for treatment of methicillin-resistant Staphylococcus aureus experimental endocarditis in rabbits.
Antimicrob Agents Chemother. 2013 Mar;57(3):1157-62. doi: 10.1128/AAC.01669-12. Epub 2012 Dec 17.
7
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Antimicrob Agents Chemother. 2004 Jan;48(1):86-92. doi: 10.1128/AAC.48.1.86-92.2004.
8
Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance.
Emerg Infect Dis. 2003 Jan;9(1):10-6. doi: 10.3201/eid0901.020172.
9
Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model.
Antimicrob Agents Chemother. 2002 May;46(5):1591-3. doi: 10.1128/AAC.46.5.1591-1593.2002.
10
Antibacterials for the prophylaxis and treatment of bacterial endocarditis in children.
Paediatr Drugs. 2001;3(10):703-18. doi: 10.2165/00128072-200103100-00001.
本文引用的文献
1
Studies on the relationship of tissue fluid and blood levels of penicillin.
J Lab Clin Med. 1951 Nov;38(5):712-8.
2
Studies relative to the chemotherapy of bacterial endocarditis.
Ann Intern Med. 1950 Nov;33(5):1224-31. doi: 10.7326/0003-4819-33-5-1224.
3
Rate of methicillin penetration into normal heart valve and experimental endocarditis lesions.
Antimicrob Agents Chemother. 1982 Mar;21(3):456-9. doi: 10.1128/AAC.21.3.456.
4
Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.
J Infect Dis. 1983 May;147(5):918-32. doi: 10.1093/infdis/147.5.918.
5
Minimal concentrations of aminoglycoside that can synergize with penicillin in enterococcal endocarditis.
Antimicrob Agents Chemother. 1981 Sep;20(3):405-9. doi: 10.1128/AAC.20.3.405.
6
Staphylococcal endocarditis in rabbits treated with a low dose of cloxacillin.
Antimicrob Agents Chemother. 1984 Mar;25(3):311-5. doi: 10.1128/AAC.25.3.311.
7
Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis.
J Antimicrob Chemother. 1984 Dec;14(6):619-31. doi: 10.1093/jac/14.6.619.
8
Cerebrospinal fluid alterations in herpes simplex virus encephalitis.
Rev Infect Dis. 1984 Sep-Oct;6(5):608-18. doi: 10.1093/clinids/6.5.608.
9
Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart.
Yale J Biol Med. 1970 Jun;42(6):394-410.
10
Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid.
J Infect Dis. 1974 Jan;129(1):73-8. doi: 10.1093/infdis/129.1.73.
Zotero 插件